DrugGen: a database of de novo-generated molecular binders for specified target proteins

Author:

Qian Hao1ORCID,Zhou Jingyuan1,Tu Shikui1ORCID,Xu Lei12ORCID

Affiliation:

1. Department of Computer Science and Engineering, Shanghai Jiao Tong University , No. 800 Dong Chuan Road, Shanghai 200240, China

2. Guangdong Institute of Intelligence Science and Technology , Building 6, No. 398 Houpu Road, Zhuhai, Guangdong 519031, China

Abstract

Abstract De novo molecular generation is a promising approach to drug discovery, building novel molecules from the scratch that can bind the target proteins specifically. With the increasing availability of machine learning algorithms and computational power, artificial intelligence (AI) has emerged as a valuable tool for this purpose. Here, we have developed a database of 3D ligands that collects six AI models for de novo molecular generation based on target proteins, including 20 disease-associated targets. Our database currently includes 1767 protein targets and up to 164 107 de novo-designed molecules. The primary goal is to provide an easily accessible and user-friendly molecular database for professionals in the fields of bioinformatics, pharmacology and related areas, enabling them to efficiently screen for potential lead compounds with biological activity. Additionally, our database provides a comprehensive resource for computational scientists to explore and compare different AI models in terms of their performance in generating novel molecules with desirable properties. All the resources and services are publicly accessible at https://cmach.sjtu.edu.cn/drug/. Database URL: https://cmach.sjtu.edu.cn/drug/.

Funder

National Natural Science Foundation of China

Publisher

Oxford University Press (OUP)

Subject

General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,Information Systems

Reference20 articles.

1. Estimation of the size of drug-like chemical space based on GDB-17 data;Polishchuk;J. Comput. Aided Mol. Des.,2013

2. New drugs cost US$2.6 billion to develop;Mullard;Nat. Rev. Drug Discov.,2014

3. Parsing clinical success rates;Mullard;Nat. Rev. Drug Discov.,2016

4. The PDBbind database: methodologies and updates;Wang;J. Med. Chem.,2005

5. A 3D generative model for structure-based drug design;Luo;Adv. Neural Inf. Process. Syst.,2021

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. DrugSynthMC: An Atom-Based Generation of Drug-like Molecules with Monte Carlo Search;Journal of Chemical Information and Modeling;2024-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3